By: Adrelia Allen, Senior Director, Clinical Trial Patient Diversity, Merck Research Clinical trials are a critical part of the research process for new medicines and vaccines. The information gained is fundamental to the development of new ways to help treat and prevent disease. Evidence has shown that some drugs and vaccines show variations in the … Continued
The post Why diversity in clinical trials matters appeared first on Atlanta Daily World.
